Ticker Details
Tenaya Therapeutics, Inc.
IPO Date:	June 30, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$134.23M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 4.68%
Avg Daily Range (30 D):	$0.03 | 4.39%
Avg Daily Range (90 D):	$0.05 | 4.58%

Institutional Daily Volume
Avg Daily Volume:	1.29M
Avg Daily Volume (30 D):	3.79M
Avg Daily Volume (90 D):	4.4M

Trade Size
Avg Trade Size (Sh.):	291
Avg Trade Size (Sh.) (30 D):	436
Avg Trade Size (Sh.) (90 D):	475

Institutional Trades
Total Institutional Trades:	109
Avg Institutional Trade:	$1.63M
Avg Institutional Trade (30 D):	$1.46M
Avg Institutional Trade (90 D):	$1.78M
Avg Institutional Trade Volume:	.44M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.02M
Avg Closing Trade (30 D):	$1.09M
Avg Closing Trade (90 D):	$1.95M
Avg Closing Volume:	696.65K

News

Nov 8, 2025 @ 4:25 PM Tenaya Therapeutics Presents Promising Interim Cli... Source: Tenaya Therapeutics

Aug 31, 2025 @ 2:15 PM Tenaya Therapeutics Presents Interim Data from MyC... Source: Tenaya Therapeutics

Mar 4, 2025 @ 3:55 PM 2025 Market Prospects of Adeno-Associated Virus Ve... Source: Researchandmarkets.Com

Jun 27, 2024 @ 9:00 PM Tenaya Therapeutics Announces Research Leadership ... Source: Tenaya Therapeutics, Inc.

Jun 18, 2024 @ 8:30 PM Tenaya Therapeutics to Participate at the TD Cowen... Source: Tenaya Therapeutics, Inc.

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.76	$-.12	$-.14
Diluted EPS	$-.76	$-.12	$-.14
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-94.26M	$-20.28M	$-23.28M
Operating Income / Loss	$-97.21M	$-20.94M	$-24.08M
Cost of Revenue
Net Cash Flow	$48.08M	$-6.36M	$8.9M
PE Ratio